pI: 7.242 |
Length (AA): 503 |
MW (Da): 54034 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
11 | 499 | 3ek1 (A) | 0 | 478 | 43.00 | 0.00000011 | 1 | 1.53157 | -0.94 |
14 | 499 | 3jz4 (A) | 1 | 478 | 45.00 | 0.0000000074 | 1 | 1.5676 | -1.06 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127004)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G79440 | succinate-semialdehyde dehydrogenase |
Brugia malayi | Bm1_35520 | Succinate semialdehyde dehydrogenase, mitochondrial precursor |
Candida albicans | CaO19.7978 | putative succinate semialdehyde dehydrogenase |
Candida albicans | CaO19.4543 | succinate-semialdehyde dehydrogenase |
Candida albicans | CaO19.345 | putative succinate semialdehyde dehydrogenase |
Candida albicans | CaO19.12018 | succinate-semialdehyde dehydrogenase |
Caenorhabditis elegans | CELE_F45H10.1 | Protein ALH-7, isoform B |
Drosophila melanogaster | Dmel_CG34349 | Unc-13 ortholog 4B (C. elegans) |
Drosophila melanogaster | Dmel_CG4685 | Succinic semialdehyde dehydrogenase |
Escherichia coli | b1525 | succinate semialdehyde dehydrogenase, NAD(P)+-dependent |
Escherichia coli | b1415 | aldehyde dehydrogenase A, NAD-linked |
Escherichia coli | b2661 | succinate-semialdehyde dehydrogenase I, NADP-dependent |
Echinococcus granulosus | EgrG_000329900 | succinate semialdehyde dehydrogenase |
Echinococcus multilocularis | EmuJ_000329700 | succinate semialdehyde dehydrogenase |
Echinococcus multilocularis | EmuJ_000329900 | succinate semialdehyde dehydrogenase |
Homo sapiens | ENSG00000112294 | aldehyde dehydrogenase 5 family, member A1 |
Leishmania braziliensis | LbrM.35.1950 | aldehyde dehydrogenase, putative |
Leishmania donovani | LdBPK_361840.1 | aldehyde dehydrogenase, putative |
Leishmania infantum | LinJ.36.1840 | aldehyde dehydrogenase, putative |
Leishmania major | LmjF.36.1760 | aldehyde dehydrogenase, putative |
Leishmania mexicana | LmxM.36.1760 | aldehyde dehydrogenase, putative |
Loa Loa (eye worm) | LOAG_07059 | hypothetical protein |
Loa Loa (eye worm) | LOAG_15055 | hypothetical protein |
Mycobacterium leprae | ML2573 | PROBABLE SUCCINATE-SEMIALDEHYDE DEHYDROGENASE [NADP+] DEPENDENT (SSDH) GABD |
Mus musculus | ENSMUSG00000035936 | aldhehyde dehydrogenase family 5, subfamily A1 |
Mycobacterium tuberculosis | Rv0768 | Probable aldehyde dehydrogenase NAD dependent AldA (aldehyde dehydrogenase [NAD+]) |
Mycobacterium tuberculosis | Rv0234c | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 |
Mycobacterium ulcerans | MUL_0477 | NAD-dependent aldehyde dehydrogenase AldA |
Mycobacterium ulcerans | MUL_1153 | succinate-semialdehyde dehydrogenase |
Mycobacterium ulcerans | MUL_0939 | NAD-dependent aldehyde dehydrogenase AldA |
Neospora caninum | NCLIV_068990 | succinate-semialdehyde dehydrogenase, putative |
Oryza sativa | 9267109 | Os02g0173900 |
Saccharomyces cerevisiae | YBR006W | succinate-semialdehyde dehydrogenase (NAD(P)(+)) |
Schistosoma japonicum | Sjp_0041240 | ko:K00139 succinate-semialdehyde dehydrogenase [EC1.2.1.24], putative |
Schistosoma mansoni | Smp_161350 | succinate semialdehyde dehydrogenase |
Schmidtea mediterranea | mk4.000206.03 | |
Schmidtea mediterranea | mk4.041773.02 | |
Schmidtea mediterranea | mk4.059086.01 | |
Schmidtea mediterranea | mk4.000206.05 | Succinate-semialdehyde dehydrogenase, mitochondrial |
Trypanosoma brucei gambiense | Tbg972.10.7560 | aldehyde dehydrogenase, putative |
Trypanosoma brucei | Tb927.10.6190 | aldehyde dehydrogenase, putative |
Trypanosoma congolense | TcIL3000_10_5250 | aldehyde dehydrogenase, putative |
Trypanosoma cruzi | TcCLB.507641.60 | aldehyde dehydrogenase, putative |
Toxoplasma gondii | TGME49_257480 | NADP-dependent succinate-semialdehyde dehydrogenase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu783 | Mycobacterium tuberculosis | non-essential | nmpdr |
Tb927.10.6190 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.6190 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.6190 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.6190 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1415 | Escherichia coli | non-essential | goodall |
b2661 | Escherichia coli | non-essential | goodall |
CELE_F45H10.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F45H10.1 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_F45H10.1 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_257480 | Toxoplasma gondii | Essentiality uncertain | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | aldehyde dehydrogenase 5 family, member A1 | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | Aldehyde dehydrogenase, cytosolic 1 | 501 aa | 35.7% | 471 aa | Compounds | References |
Rattus norvegicus | Aldehyde dehydrogenase 1A1 | 501 aa | 35.7% | 471 aa | Compounds | References |
1 literature reference was collected for this gene.